The BENEFIT Trial: Where do we go from here?

by Pécoul B, Batista C, Stobbaerts E, Ribeiro I, Vilasanjuan R, Gascon J, Pinazo MJ, Moriana S, Gold S, Pereiro A, Navarro M, Torrico F, Bottazzi ME, Hotez PJ. PLOS Neglected Tropical Diseases 2016. 10(2): e0004343. doi:10.1371/journal.pntd.0004343

Summary: The commentary discusses the results and implications of the recently published BENEFIT trial. In the next five years, we can now project that 200,000 people living with Chagas disease will die from heart disease and related complications. We urgently need to redouble our efforts to identify and treat young people who are still in the early stages of their illness, but ultimately we need to find better treatments and new cures.

Click here to read the article / PDF